Cognitive-behavioral therapy for management of anxiety and medication taper in older adults

American Journal of Geriatric Psychiatry

Volumn 13, Issue 10, 2005, Pages 901-909

  Gorenstein, Ethan E ^c   Kleber, Marc S ^c   Mohlman, Jan ^b   DeJesus, Marybeth ^c   Gorman, Jack M ^a   Papp, Laszlo A ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Box 427 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; DIAZEPAM; DIPHENHYDRAMINE; MEPROBAMATE; OPIATE; SEROTONIN UPTAKE INHIBITOR; VALERIAN; BENZODIAZEPINE DERIVATIVE; NARCOTIC AGENT;

AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ELDERLY CARE; FOLLOW UP; HUMAN; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PHOBIA; RANDOMIZED CONTROLLED TRIAL; SOMATIZATION; TREATMENT WITHDRAWAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; MALE; METHODOLOGY;

AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NARCOTICS;

EID: 28544442897     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/00019442-200510000-00010     Document Type: Article

References (25)

1. Rifkin A: Benzodiazepine use and abuse by patients at outpatient clinics. Am J Psychiatry 1989; 146:1331-1332
2. Salzman C: Geriatric psychopharmacology. Annu Rev Med 1985; 36:217-228
3. Parry HJ: National patterns of psychotherapeutic drug use. Arch Gen Psychiatry 1973; 28:769-783
4. Salzman C: Pharmacologic treatment of the anxious elderly patient, in Anxiety in the Elderly. Edited by Salzman C, Lebowitz BD. New York, Springer, 1991, pp 149-173
5. Shaw SM, Opit LJ: Need for supervision in the elderly receiving long-term prescribed medication. BMJ 1976; 1:505-507
6. Wang PS, Bohn RL, Glynn RJ, et al: Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158:892-898
7. American Psychiatric Association: Benzodiazepine dependence, toxicity, and abuse: A Task Force Report of the American Psychiatric Association. Washington, DC, The American Psychiatric Association, 1990
8. Borkovec TD, Costello E: Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 1993; 55:611-619
9. Stanley MA, Beck JG, Novy DM, et al: Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol 2003; 71:309-319
10. Wetherell JM, Gatz M, Craske MG: Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol 2003; 71:31-40
11. Otto MW, Pollack MH, Sachs GS: Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral treatment for patients with panic disorder. Am J Psychiatry 1993; 150:1485-1490
12. Sable JA, Jeste DV: Anxiety disorders in older adults. Curr Psychiatry Rep 2001; 4:302-307
13. Sheikh JI: Anxiety rating scales for the elderly, in Anxiety in the Elderly. Edited by Salzman C, Lebowitz BD. New York, Springer, 1992, pp 251-265
14. First MB, Gibbon M, Spitzer RL, et al: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-IV). New York, Biometrics Dept., New York State Psychiatric Institute, 1995
15. Spielberger CD: Manual for the State-Trait Anxiety Inventory (STAI). Baltimore, MD, Johns Hopkins, 1983
16. Meyer T, Miller M, Metzger R, et al: Development and validity of The Penn State Worry Scale. Behavior Research and Therapy 1990; 28:487-495
17. Beck AT, Steer RA, Brown GK: Beck Depression Inventory Manual, 2nd Edition. San Antonio, TX, The Psychological Corp., 1996
18. Derogatis LR: Symptom Checklist-90, Revised (SCL-90): administration, scoring, and procedures for the revised version. Baltimore, MD, Clinical Psychometric Research, 1994
19. Guy W: Assessment Manual for Psychopharmacology, Revised (DHEW Publ. ADM 76-338). Washington, DC, U.S. Govt. Printing Office, 1976
20. Mattis S: Dementia Rating Scale, Professional Manual. Odessa, FL, Psychological Assessment Resources, Inc., 1988
21. Scott NW, McPherson GC, Ramsay CR, et al: The method of minimization for allocation to clinical trials: a review. Controlled Clinical Trials 2002; 23:662-674
22. Craske MG, Barlow DH: Panic disorder and agoraphobia, in Clinical Handbook of Psychological Disorders, 2nd Edition. Edited by Barlow DH. New York, Guilford, 1993, pp 1-47
23. Brown TA, O'Leary TA, Barlow DH: Generalized anxiety disorder, in Clinical Handbook of Psychological Disorders, 2nd Edition. Edited by Barlow DH. New York, Guilford, 1993, pp 137-188
24. Gorenstein EE, Papp LA, Kleber MS: Cognitive-behavioral treatment of anxiety in later life. Cognitive and Behavioral Practice 1999; 6:305-319
25. Bagiella E, Sloan RP, Heitjan DF: Mixed-effects models in psychophysiology. Psychophysiology 2000; 37:13-20